Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells
Table 5
Changes in the proportion of PBL subsets in patients before and after treatment (%).
NAs group
NAs + FZHY group
n
Pre
Post
Post-Pre
n
Pre
Post
Post-Pre
CD4+T cells
35
35.72 ± 10.10
35.40 ± 10.68
−0.32 ± 11.98
35
32.16 ± 8.19
37.39 ± 9.17
5.22 ± 9.96△
CD8+T cells
35
31.55 ± 9.38
32.72 ± 10.52
1.17 ± 12.71
35
30.18 ± 5.58
28.89 ± 9.55
−1.28 ± 10.97
NK cells
35
16.43 ± 7.13
16.70 ± 9.25
0.31 ± 5.99
35
17.64 ± 7.15
21.14 ± 8.97△△
3.19 ± 5.12
versus Pre CD4+T cells of NAs + FZHY group; versus Post-Pre CD4+T cells of NAs group; versus Pre NK cells of NAs + FZHY group. PBL, peripheral blood lymphocyte.
